Discover

STSS
Sharps Technology Inc
1.84
2 x 1.38
2 x 2.35
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
1.87 +0.03 (1.63%)
Ytd-9.36%
1y-68.76%
1.84
day range
1.84
1.70
52 week range
18.15
Open1.96Prev Close1.84Low1.84High1.84Mkt Cap3.33M
Vol519.43KAvg Vol195.74KEPS-8.24P/EN/AForward P/E-12.33
Beta1.19Short Ratio0.38Inst. Own4.03%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg2.76200-d Avg5.141yr Est352.00
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-142024-090-1.27N/AN/A
2024-08-142024-060-2.2N/AN/A
2024-05-142024-030-1.1N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2023-05-09Aegis CapitalUpgradeBuy
Profile
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Insider Holder
DateNameRelationQuantityDescription
2023-12-27CRESCENZO ANDREW RChief Financial Officer15.50KPurchase
2024-02-19HAYES ROBERT MICHAELChief Executive Officer95.88KPurchase
2024-01-02RUEMLER TIMOTHY JAMESDirector1.06MPurchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Essential Planning, Llc. 7.40K13.69K0.41%
2024-09-29Renaissance Technologies, LLC6.22K11.51K0.35%
2024-09-29Org Partners LLC 4.55K8.41K0.25%
2024-09-29AlphaCore Capital, LLC4.03K7.45K0.22%
2024-09-29Compass Ion Advisors, LLC2.60K4.80K0.14%
2024-09-29HRT Financial LP1.64K3.04K0.09%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-06-29Vanguard Extended Market Index Fund453.00838.000.03%
Split
SplitDate
1 : 3002025-04-28
1 : 222024-10-16